Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 3
2004 7
2005 4
2006 8
2007 3
2008 7
2009 5
2010 6
2011 8
2012 3
2013 10
2014 9
2015 1
2016 3
2017 6
2018 5
2019 4
2020 1
2021 3
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team. Piccart-Gebhart MJ, et al. Among authors: inbar m. N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306. N Engl J Med. 2005. PMID: 16236737 Free article. Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Among authors: inbar m. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Plant coloration undermines herbivorous insect camouflage.
Lev-Yadun S, Dafni A, Flaishman MA, Inbar M, Izhaki I, Katzir G, Ne'eman G. Lev-Yadun S, et al. Among authors: inbar m. Bioessays. 2004 Oct;26(10):1126-30. doi: 10.1002/bies.20112. Bioessays. 2004. PMID: 15382135 Review.
Palliative treatment for advanced or metastatic osteosarcoma.
Merimsky O, Kollender Y, Inbar M, Meller I, Bickels J. Merimsky O, et al. Among authors: inbar m. Isr Med Assoc J. 2004 Jan;6(1):34-8. Isr Med Assoc J. 2004. PMID: 14740508 Free article. Review. No abstract available.
PET in women with high risk for breast or ovarian cancer.
Even-Sapir E, Inbar M. Even-Sapir E, et al. Among authors: inbar m. Lancet Oncol. 2010 Sep;11(9):899-905. doi: 10.1016/S1470-2045(10)70022-X. Epub 2010 Jul 7. Lancet Oncol. 2010. PMID: 20615754 Review.
Developing a large-scale dataset of flood fatalities for territories in the Euro-Mediterranean region, FFEM-DB.
Papagiannaki K, Petrucci O, Diakakis M, Kotroni V, Aceto L, Bianchi C, Brázdil R, Gelabert MG, Inbar M, Kahraman A, Kılıç Ö, Krahn A, Kreibich H, Llasat MC, Llasat-Botija M, Macdonald N, de Brito MM, Mercuri M, Pereira S, Řehoř J, Geli JR, Salvati P, Vinet F, Zêzere JL. Papagiannaki K, et al. Among authors: inbar m. Sci Data. 2022 Apr 12;9(1):166. doi: 10.1038/s41597-022-01273-x. Sci Data. 2022. PMID: 35414083 Free PMC article.
99 results